These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 29766785)

  • 1. Pharmaceutical Strategies for Stabilizing Drug Nanocrystals.
    Yang H; Kim H; Jung S; Seo H; Nida SK; Yoo SY; Lee J
    Curr Pharm Des; 2018; 24(21):2362-2374. PubMed ID: 29766785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progress in the development of stabilization strategies for nanocrystal preparations.
    Li J; Wang Z; Zhang H; Gao J; Zheng A
    Drug Deliv; 2021 Dec; 28(1):19-36. PubMed ID: 33336609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug nanosuspensions: a ZIP tool between traditional and innovative pharmaceutical formulations.
    Leone F; Cavalli R
    Expert Opin Drug Deliv; 2015; 12(10):1607-25. PubMed ID: 25960000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanocrystals: An Overview of Fabrication, Characterization and Therapeutic Applications in Drug Delivery.
    Pardhi VP; Verma T; Flora SJS; Chandasana H; Shukla R
    Curr Pharm Des; 2018; 24(43):5129-5146. PubMed ID: 30767737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding Critical Quality Attributes for Nanocrystals from Preparation to Delivery.
    Peltonen L; Strachan C
    Molecules; 2015 Dec; 20(12):22286-300. PubMed ID: 26703528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanocrystal Based Drug Delivery System: Conventional and Current Scenario.
    Thakkar S; Shah V; Misra M; Kalia K
    Recent Pat Nanotechnol; 2017 Jul; 11(2):130-145. PubMed ID: 27758683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is the combination of cellulosic polymers and anionic surfactants a good strategy for ensuring physical stability of BCS Class II drug nanosuspensions?
    Bilgili E; Li M; Afolabi A
    Pharm Dev Technol; 2016; 21(4):499-510. PubMed ID: 25774989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanocrystals Technology for Improving Bioavailability of Poorly Soluble Drugs: A Mini-Review.
    Zhou Y; Du J; Wang L; Wang Y
    J Nanosci Nanotechnol; 2017 Jan; 17(1):18-28. PubMed ID: 29616786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanocrystals: A Deep Insight into Formulation Aspects, Stabilization Strategies, and Biomedical Applications.
    Purohit D; Sharma S; Lamba AK; Saini S; Minocha N; Vashist N; Kaushik D; Pandey P
    Recent Pat Nanotechnol; 2023; 17(4):307-326. PubMed ID: 35616680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of precipitation methods for the production of water-insoluble drug nanocrystals: production techniques and stability of nanocrystals.
    Xia D; Gan Y; Cui F
    Curr Pharm Des; 2014; 20(3):408-35. PubMed ID: 23651396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efavirenz Dissolution Enhancement IV-Antisolvent Nanocrystallization by Sonication, Physical Stability, and Dissolution.
    Sartori GJ; Prado LD; Rocha HVA
    AAPS PharmSciTech; 2017 Nov; 18(8):3011-3020. PubMed ID: 28493004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Research progress on the preparation and application of flavonoid nanocrystals.
    Tian Y; Shi Z; Ma H
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2023 Jun; 52(3):338-348. PubMed ID: 37476945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanocrystallization by evaporative antisolvent technique for solubility and bioavailability enhancement of telmisartan.
    Bajaj A; Rao MR; Pardeshi A; Sali D
    AAPS PharmSciTech; 2012 Dec; 13(4):1331-40. PubMed ID: 23054986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmaceutical nanocrystals by nanomilling: critical process parameters, particle fracturing and stabilization methods.
    Peltonen L; Hirvonen J
    J Pharm Pharmacol; 2010 Nov; 62(11):1569-79. PubMed ID: 21039542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Production of nanosuspensions as a tool to improve drug bioavailability: focus on topical delivery.
    Lai F; Schlich M; Pireddu R; Corrias F; Fadda AM; Sinico C
    Curr Pharm Des; 2015; 21(42):6089-103. PubMed ID: 26503149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploration of alginates as potential stabilizers of nanosuspension.
    Guan J; Zhang Y; Liu Q; Zhang X; Chokshi R; Mao S
    AAPS PharmSciTech; 2017 Nov; 18(8):3172-3181. PubMed ID: 28536795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug nanocrystals - Versatile option for formulation of poorly soluble materials.
    Peltonen L; Hirvonen J
    Int J Pharm; 2018 Feb; 537(1-2):73-83. PubMed ID: 29262301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent developments in the use of nanocrystals to improve bioavailability of APIs.
    Ding Y; Zhao T; Fang J; Song J; Dong H; Liu J; Li S; Zhao M
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2024; 16(2):e1958. PubMed ID: 38629192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of surface stabilized candesartan cilexetil nanocrystals with enhanced dissolution rate, permeation rate across CaCo-2, and oral bioavailability.
    Jain S; Reddy VA; Arora S; Patel K
    Drug Deliv Transl Res; 2016 Oct; 6(5):498-510. PubMed ID: 27129488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of stabilizing agents on the development of myricetin nanosuspension and its characterization: an in vitro and in vivo evaluation.
    Hong C; Dang Y; Lin G; Yao Y; Li G; Ji G; Shen H; Xie Y
    Int J Pharm; 2014 Dec; 477(1-2):251-60. PubMed ID: 25445518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.